Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study

ConclusionsPostoperative renal morbidity and mortality did not differ between patients receiving HES 130/0.4 and those receiving albumin. HES 130/0.4 was associated with shorter hospital stay and less fluid requirement compared to albumin. These findings support the use of 6% HES 130/0.4 for perioperative volume replacement as an alternative to albumin.Trial registrationUMIN000027896 and the date of registration was June 30, 2017 athttps://www.umin.ac.jp/ctr/index-j.html.
Source: Journal of Anesthesia - Category: Anesthesiology Source Type: research